Literature DB >> 12519935

Tenofovir disoproxil fumarate in patients with HIV and lamivudine-resistant hepatitis B virus.

Yves Benhamou, Roland Tubiana, Vincent Thibault.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12519935     DOI: 10.1056/NEJM200301093480218

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  20 in total

Review 1.  Emerging drugs for hepatitis B.

Authors:  Fabien Zoulim
Journal:  Expert Opin Emerg Drugs       Date:  2007-05       Impact factor: 4.191

Review 2.  Management of chronic hepatitis B in patients from special populations.

Authors:  Ching-Lung Lai; Man-Fung Yuen
Journal:  Cold Spring Harb Perspect Med       Date:  2015-06-01       Impact factor: 6.915

3.  Tenofovir disoproxil fumarate for the treatment of chronic hepatitis B monoinfection.

Authors:  Wai-Kay Seto; Man-Fung Yuen; James Fung; Ching-Lung Lai
Journal:  Hepatol Int       Date:  2011-06-19       Impact factor: 6.047

4.  Antiviral effects of lamivudine, emtricitabine, adefovir dipivoxil, and tenofovir disoproxil fumarate administered orally alone and in combination to woodchucks with chronic woodchuck hepatitis virus infection.

Authors:  Stephan Menne; Scott D Butler; Andrea L George; Ilia A Tochkov; Yuao Zhu; Shelly Xiong; John L Gerin; Paul J Cote; Bud C Tennant
Journal:  Antimicrob Agents Chemother       Date:  2008-08-01       Impact factor: 5.191

Review 5.  Management of hepatitis B in patients coinfected with the human immunodeficiency virus.

Authors:  R Lessells; C Leen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-04-27       Impact factor: 3.267

6.  Hepatitis B in HIV: available treatment options and approach to therapy.

Authors:  Melissa Osborn
Journal:  Curr Infect Dis Rep       Date:  2009-09       Impact factor: 3.725

7.  Antiviral efficacies of currently available rescue therapies for multidrug-resistant chronic hepatitis B.

Authors:  Mi Sung Park; Beom Kyung Kim; Kyung Sik Kim; Ja Kyung Kim; Seung Up Kim; Jun Yong Park; Do Young Kim; Oidov Baartarkhuu; Kwang Hyub Han; Chae Yoon Chon; Sang Hoon Ahn
Journal:  Clin Mol Hepatol       Date:  2013-03-25

Review 8.  Evaluation and treatment of the patient coinfected with hepatitis B and HIV.

Authors:  Ellen Kitchell; Mamta K Jain
Journal:  Curr HIV/AIDS Rep       Date:  2008-08       Impact factor: 5.071

9.  Delayed chain termination protects the anti-hepatitis B virus drug entecavir from excision by HIV-1 reverse transcriptase.

Authors:  Egor P Tchesnokov; Aleksandr Obikhod; Raymond F Schinazi; Matthias Götte
Journal:  J Biol Chem       Date:  2008-10-20       Impact factor: 5.157

Review 10.  Future prospectives for the management of chronic hepatitis B.

Authors:  W F Leemans; H L A Janssen; R A de Man
Journal:  World J Gastroenterol       Date:  2007-05-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.